Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

[1]  Kelly R Evenson,et al.  Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer , 2017, Medicine and science in sports and exercise.

[2]  Richard F. MacLehose,et al.  Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study , 2017, JAMA internal medicine.

[3]  A. Folsom,et al.  Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study , 2016, Journal of thrombosis and haemostasis : JTH.

[4]  N. Roetker,et al.  Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities) , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[5]  A. Folsom,et al.  Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. , 2016, Thrombosis research.

[6]  Robert Paine,et al.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. , 2016, The New England journal of medicine.

[7]  S. Hart,et al.  Coagulation and anticoagulation in idiopathic pulmonary fibrosis , 2015, European Respiratory Review.

[8]  A. Folsom,et al.  Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study. , 2015, Circulation.

[9]  B. Nordestgaard,et al.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. , 2013, JAMA.

[10]  Benjamin M. Smith,et al.  Pulmonary Hyperinflation and Left Ventricular Mass: The Multi-Ethnic Study of Atherosclerosis COPD Study , 2013, Circulation.

[11]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[12]  M. Eagleton Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles , 2012, Vascular.

[13]  J. Hamming,et al.  An association between chronic obstructive pulmonary disease and abdominal aortic aneurysm beyond smoking: results from a case-control study. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[14]  H Völzke,et al.  Airflow limitation, lung volumes and systemic inflammation in a general population , 2011, European Respiratory Journal.

[15]  G. Mancia,et al.  Left ventricular hypertrophy and abdominal aorta size in essential hypertension , 2011, Journal of hypertension.

[16]  T. McKeever,et al.  The Association Between Blood Coagulation Activity and Lung Function: A Population-Based Study , 2010, PloS one.

[17]  Mario Cazzola,et al.  Prevalence of Comorbidities in Patients with Chronic Obstructive Pulmonary Disease , 2010, Respiration.

[18]  P. Tsao,et al.  Circulating markers of abdominal aortic aneurysm presence and progression. , 2008, Circulation.

[19]  Emiel F M Wouters,et al.  Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. , 2007, Proceedings of the American Thoracic Society.

[20]  C. Anandan,et al.  Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. , 2006, Journal of vascular surgery.

[21]  D. Mannino,et al.  Lung function decline and outcomes in an elderly population , 2005, Thorax.

[22]  Demosthenes Bouros,et al.  Respiratory Research BioMed Central Review Serum biomarkers in interstitial lung diseases , 2005 .

[23]  U. P. S. T. Force,et al.  Screening for Abdominal Aortic Aneurysm: Recommendation Statement , 2005, Annals of Internal Medicine.

[24]  W. Pearce,et al.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation , 1994, Agents and Actions.

[25]  RAP Scott,et al.  The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial , 2002, The Lancet.

[26]  F. Sakamaki,et al.  Higher prevalence of obstructive airway disease in patients with thoracic or abdominal aortic aneurysm. , 2002, Journal of vascular surgery.

[27]  M. Cotrufo,et al.  Association of Left Ventricular Hypertrophy and Aortic Dilation in Patients with Acute Thoracic Aortic Dissection , 2001, Angiology.

[28]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[29]  P. Kiener,et al.  Activation of human monocytes through CD40 induces matrix metalloproteinases. , 1996, Journal of immunology.

[30]  K. Newman,et al.  Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. , 1994, Circulation.

[31]  J. Dayer,et al.  Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. , 1994, The Journal of biological chemistry.

[32]  M. Lewis,et al.  Ultrasonographic screening for abdominal aortic aneurysm in an urban community , 1994, The British journal of surgery.

[33]  W. Pearce,et al.  Interleukin-1β and tumor necrosis factor-α release in normal and diseased human infrarenal aortas * ** * , 1992 .

[34]  W. Pearce,et al.  Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. , 1992, Journal of vascular surgery.

[35]  R. Limet,et al.  Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. , 1991, Journal of vascular surgery.

[36]  O. Ekberg,et al.  A population based screening of abdominal aortic aneurysms (AAA). , 1991, European journal of vascular surgery.

[37]  Aric Invest The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[38]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[39]  T. M. Silver,et al.  Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms. , 1985, Surgery.

[40]  K. Geisinger,et al.  Serum uric acid. , 1979, American journal of clinical pathology.

[41]  B. Ferris,et al.  Epidemiology Standardization Project (American Thoracic Society). , 1978, The American review of respiratory disease.